CANCER TREATMENT CONTINUES TO GET SMARTER as more companies pursue a marriage of molecular diagnostics and available therapies. This same trend is emerging beyond cancer, as diagnostics are refining patient subsets in a wide range of diseases, and matching them with new drugs. While this approach got off to a slow start, it is gathering popularity at last.
http://lnkd.in/sDAMia